temozolomide has been researched along with Myxoid Liposarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uboldi, S | 1 |
| Bernasconi, S | 1 |
| Romano, M | 1 |
| Marchini, S | 1 |
| Fuso Nerini, I | 1 |
| Damia, G | 1 |
| Ganzinelli, M | 1 |
| Marangon, E | 1 |
| Sala, F | 1 |
| Clivio, L | 1 |
| Chiorino, G | 1 |
| Di Giandomenico, S | 1 |
| Rocchi, M | 1 |
| Capozzi, O | 1 |
| Margison, GP | 1 |
| Watson, AJ | 1 |
| Caccuri, AM | 1 |
| Pastore, A | 1 |
| Fossati, A | 1 |
| Mantovani, R | 1 |
| Grosso, F | 1 |
| Tercero, JC | 1 |
| Erba, E | 1 |
| D'Incalci, M | 1 |
1 other study available for temozolomide and Myxoid Liposarcoma
| Article | Year |
|---|---|
Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; C-Reactive Protein; CCAAT-Enhancer-Binding Protein-alp | 2012 |